Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes.
An early event in death of interphase lymphocytes exposed in vivo or in vitro to low doses of gamma-irradiation is the degradation of DNA into nucleosome-sized fragments. Induction of fragmentation required RNA and protein synthesis because actinomycin D and cycloheximide, respectively, are able to inhibit DNA fragmentation in irradiated lymphocytes. Studies adding cycloheximide and actinomycin D at various times postirradiation suggest that once the metabolic process is initiated within an individual cell it proceeds to completion. The reversible RNA synthesis inhibitor, 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole inhibits DNA fragmentation in irradiated thymocytes. When this drug is removed after 6 hr, irradiated thymocytes proceed to fragment their DNA; this suggests that an inducing "signal" that is not simply mRNA persists within the irradiated cell for at least 6 hr after irradiation. In contrast to mitogen-activated T and B lymphoblasts, resting T and B cells show significant DNA fragmentation after exposure to 100 to 500 rad. At 2000 rad, all of the splenic subpopulations die rapidly via a different mechanism. By studying the mechanism of DNA fragmentation induced during the interphase death of lymphocytes, we hope to understand better the extreme sensitivity of resting lymphocytes to radiation and what may be the common final pathway of programmed cell death.
Sellins
K S
KS
Department of Microbiology and Immunology, University of Colorado School of Medicine, Denver 80262.
Cohen
J J
JJ
D000818:Animals; D002470:Cell Survival / Q000528:radiation effects*; D004249:DNA Damage; D003864:Depression, Chemical; D005720:Gamma Rays; D005786:Gene Expression Regulation / Q000528:radiation effects*; D007399:Interphase; D008214:Lymphocytes / Q000528:radiation effects* / Q000648:ultrastructure; D051379:Mice; D008807:Mice, Inbred BALB C; D014176:Protein Biosynthesis / Q000187:drug effects; D011836:Radiation Tolerance; D014158:Transcription, Genetic / Q000187:drug effects; D015533:Transcriptional Activation